Company Description
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally.
It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors.
It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand.
In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands.
Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods.
Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
| Country | United States |
| Founded | 1981 |
| IPO Date | Aug 23, 1989 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,636 |
| CEO | Mikhael Nassif |
Contact Details
Address: 620 Lesher Place Lansing, Michigan 48912-1595 United States | |
| Phone | 517 372 9200 |
| Website | neogen.com |
Stock Details
| Ticker Symbol | NEOG |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | June - May |
| Reporting Currency | USD |
| CIK Code | 0000711377 |
| CUSIP Number | 640491106 |
| ISIN Number | US6404911066 |
| Employer ID | 38-2367843 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Mikhael Nassif | Chief Executive Officer, President and Director |
| R. Bryan Riggsbee CPA | Chief Financial Officer and Senior Vice President |
| John Moylan | Vice President, Corporate Controller and Chief Accounting Officer |
| Dr. Jeremy Yarwood | Chief Scientific Officer |
| Sarah Demey | Administrative Manager |
| Bill Waelke | Head of Investor Relations |
| Jennifer Evans Stacey Esq., J.D. | Chief Legal and Compliance Officer and Board Secretary |
| Kevin M. Burke | Chief Human Resources Officer |
| Joe Freels | Senior Vice President and Chief Commercial Officer |
| Dr. Tamara A. Ranalli Ph.D. | Senior Vice President and GM of Global Food Safety |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 30, 2026 | 10-K | Annual Report |
| Jul 30, 2026 | 8-K | Current Report |
| Jul 7, 2026 | SCHEDULE 13G | Filing |
| Jun 25, 2026 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 3, 2026 | 144 | Filing |
| May 29, 2026 | 144 | Filing |
| May 20, 2026 | SD | Form - SD |
| May 14, 2026 | SCHEDULE 13G/A | Filing |
| Apr 30, 2026 | SCHEDULE 13G | Filing |
| Apr 29, 2026 | SCHEDULE 13G | Filing |